Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/16/24 16:24 | 7/12/24 | EYPT | Electr | LabEq | Laboratory Analytical Instrum | Guyer David R | MA | D | 2 | S.d | -264 | 11.36 | 0 | -23 | 6 | D | ||||||||||||||||
2/5/24 17:15 | 2/2/24 | EYPT | Electr | LabEq | Laboratory Analytical Instrum | Jones David Scott | MA | O | SVP,Chie | 4 | S.dm | -1,759 | 24.03 | 0 | -73 | 38 | D | |||||||||||||||
1/30/24 16:53 | 1/26/24 | EYPT | Electr | LabEq | Laboratory Analytical Instrum | Paggiarino Dario A. | MA | O | Chief Me | 6 | S.dm | -2,877 | 23.72 | 0 | -121 | 37 | D | |||||||||||||||
1/25/24 18:24 | 1/23/24 | EYPT | Electr | LabEq | Laboratory Analytical Instrum | Lurker Nancy | MA | DO | Exec Vic | 2 | S.dm | -1,289 | 23.44 | 0 | -55 | 188 | D | |||||||||||||||
1/16/24 18:55 | 1/11/24 | EYEP | Electr | LabEq | Laboratory Analytical Instrum | Ocumension Therapeutics | F4 | D | 2 | S.m | -56,670 | 19.47 | 0 | -2,911 | 2,011 | D | ||||||||||||||||
1/16/24 18:01 | 1/11/24 | EYPT | Electr | LabEq | Laboratory Analytical Instrum | Liu Ye | D | 2 | S.m | -56,670 | 19.47 | 0 | -2,911 | 2,011 | I | |||||||||||||||||
12/11/23 16:15 | 12/4/23 | EYPT | Electr | LabEq | Laboratory Analytical Instrum | Pine Michael Craig | MA | O | Chief Co | 2 | S.d | -2,001 | 21.99 | 0 | -91 | 5 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |